GeoVax Labs, Inc.
General ticker "GOVX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $15.2M (TTM average)
GeoVax Labs, Inc. does not follow the US Stock Market performance with the rate: -11.9%.
Estimated limits based on current volatility of 4.8%: low 0.38$, high 0.41$
Factors to consider:
- Total employees count: 12 as of 1996
- Current price 74.4% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.50$, 4.75$]
- 2025-12-31 to 2026-12-31 estimated range: [1.10$, 3.60$]
Financial Metrics affecting the GOVX estimates:
- Positive: with PPE of -0.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -203.49 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: 41.86 < Shareholder equity ratio, % of 61.90 <= 63.39
- Positive: Investing cash flow per share per price, % of -0.17 > -0.66
Short-term GOVX quotes
Long-term GOVX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.08MM | $0.00MM | $3.95MM |
| Operating Expenses | $14.11MM | $26.74MM | $29.10MM |
| Operating Income | $-14.03MM | $-26.74MM | $-25.14MM |
| Non-Operating Income | $0.01MM | $0.78MM | $0.15MM |
| Interest Expense | $0.00MM | $0.00MM | $0.02MM |
| R&D Expense | $9.12MM | $20.72MM | $23.71MM |
| Income(Loss) | $-14.02MM | $-25.97MM | $-24.99MM |
| Profit(Loss)* | $-14.02MM | $-25.97MM | $-24.99MM |
| Stockholders Equity | $26.60MM | $5.76MM | $5.05MM |
| Assets | $31.35MM | $9.28MM | $8.16MM |
| Operating Cash Flow | $-19.03MM | $-25.17MM | $-24.68MM |
| Capital expenditure | $0.13MM | $0.05MM | $0.02MM |
| Investing Cash Flow | $-0.13MM | $-0.05MM | $-0.02MM |
| Financing Cash Flow | $35.35MM | $4.06MM | $23.75MM |
| Earnings Per Share** | $-5.52 | $-10.22 | $-4.82 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.